Stock Taper
Nyxoah S.A. is a Belgian medical tech company developing and commercializing the Genio system, a CE-marked hypoglossal neurostimulation therapy for treating moderate to severe obstructive sleep apnea.

The Genio system is a leadless, battery-free implantable neurostimulation device that treats moderate to severe Obstructive Sleep Apnea by stimulating the hypoglossal nerve to maintain airway openness, offering an alternative for patients intolera...
| Map | REGION | Q3-2022 | Q4-2022 | Q2-2023 | Q4-2023 |
|---|---|---|---|---|---|
![]() | GERMANY | $15K | $2.79M ▲ | $1M ▼ | — |
![]() | AUSTRIA | — | — | $81K | $41K ▼ |
![]() | SWITZERLAND | $167K | $47K ▼ | $23K ▼ | — |
Overall rating: C
| PEER | PRICE | |
|---|---|---|
OABI | $4.33 | COMPARE |
PRE | $20.20 | COMPARE |
IVVD | $1.00 | COMPARE |
OSUR | $3.88 | COMPARE |
UTMD | $71.55 | COMPARE |
TARA | $3.85 | COMPARE |
STIM | $3.00 | COMPARE |
KRMD | $3.21 | COMPARE |